News 
Market Data 
Discover
Replies to post #416141 on NorthWest Biotherapeutics Inc (NWBO)
11/09/21 2:20 PM
11/10/21 9:55 AM
maverick_1 Friday, 06/14/19 02:59:26 PM
Re: maverick_1 post# 233200 0
Post # of 416289
IMHO NWBO CEO Linda Powers sold 4.4 mln shs at 17 cts: a small part of her NWBO shrs/options at yrend '18 at a SUBSTANTIAL LT Cap LOSS to clearly OFFSET her LARGE LT CapGAIN from the MLBO SALE of Cognate BioServices (CB):
NWBO Tax Side:
1)Safe to say that the NWBO shares used for the above were BOUGHT as high as $180: see this LT chart:http://bigcharts.marketwatch.com/quickchart/quickchart.asp?symb=NWBO&insttype=&freq=2&show=&time=20
2) CEO Linda Powers sold 4.4 mln NWBO shrs @ 17 CENTS
Cognate BioServices (CB) Tax Side:
1) CB was a NEW Memphis, TN bought 2005? from bankruptcy court in the liquidation of Gene SYS?
2) In the last few years that facility was substantially expanded
3) I indicated within the last two weeks IMHO Cognate BioServices likely was sold in EXCESS of $75 mln
4) In the last 4 yrs "similar" plants were SOLD:
a)Caladrius Biosciences (CLBS)sold it's CA plant
Quote:
Hitachi Chemical Signs Agreement to Purchase from Caladrius Biosciences the Remaining 80.1% Interest in PCT for $75 Million
March 16, 2017
https://www.caladrius.com/press-release/hitachi-chemical-signs-agreement-to-purchase-from-caladrius-biosciences-the-remaining-80-1-interest-in-pct-for-75-million/
CLBS is but one of a handful of BOMBED OUT Buy recommendations by Steve G (Pyrrh + 5 other alias')
b) Novartis spent $43 mln in 2013! to acquire south NJ Dendreon plant when the later was under financial stress due to CLEAR INeptitude from MANY perspectives of CEO Mitch Gold:
Quote:
Dendreon today said it sold to Novartis its immunotherapy manufacturing facility in Morris Plains, NJ, for $43 million cash—the latest move by the troubled prostate cancer drug developer to right its own ship following more than a year of weaker-than-expected sales.
https://www.genengnews.com/topics/bioprocessing/troubled-dendreon-sells-off-nj-plant/
I will NOT spend more time on the above as I have already demonstrated in SPADES and across a wide spectrum the level of clear inexperience aside from EGO of NWBO owners or Naysayers.
That's why I always go the EXTRA MILE!
Just like what CEO Linda Powers has done in the last few years.
AND IMPORTANTLY others may react: Narcissistic through their OWN EGO or feel threatened.
ONCE AND FOR ALL:
Everything I have indicated is the furthest from that of being narcissistic or egotistic
Even without experience in a WIDE spectrum of high level encounters I have with an OPEN MIND: excelled.
That's why:
DIFFERENT STROKES FOR DIFFERENT FOLKS
flipper44
RE: maverick_1 post# 233327
Post# of 416290 Go
Friday, 06/14/2019 03:02:23 PM
PlusOneCoin Icon
0
You did go the extra mile on that. Thanks. Makes sense.
Respond |
No Replies
exwannabe
RE: maverick_1 post# 233327
Post# of 416290 Go
Friday, 06/14/2019 04:13:54 PM
PlusOneCoin Icon
0
Quote:
IMHO NWBO CEO Linda Powers sold 4.4 mln shs at 17 cts: a small part of her NWBO shrs/options at yrend '18 at a SUBSTANTIAL LT CapLOSS to clearly OFFSET her LARGE LT CapGAIN from the MLBO SALE of Cognate BioServices (CB):
NWBO Tax Side:
1)Safe to say that the NWBO shares used for the above were BOUGHT as high as $180: see this LT chart:bigcharts.marketwatch.com/quickchart/quickchart.asp?symb=NWBO&insttype=&freq=2&show=&time=20
Nope.
The D-2 warrants in the transaction (which were exactly half of the restricted shares) only existed in conjunction with the recent preferred shares. And if the sale was those pref. and attached warrants, it likely was at $0 profit/loss.
True though that she certainly took a large cap gains hit on Cognate. Nice of NWBO to pay to build them up.
Respond |
View Replies (2)
profile pic maverick_1
RE: maverick_1 post# 233327
Post# of 416290 Go
Wednesday, 06/26/2019 04:54:21 PM
PlusOneCoin Icon
0
CEO Linda Powers HAS GNORMOUS unrealized NWBO LOSSES beyond one's comprehension! (really need a full time acclaimed Accounting FORENSIC to unearth going back to 2004!! TO PRESENT!!
Clearly exceeds by many orders of magnitude that of BasinStBlues investment consortium.
This can only change with top line approval!
Today is the first day I'm delving into the above! VERY TIME & LABOR INTENSIVE and the crew of distortnists can dredge up whatever: Par 4 the Course!
NONE OF THE ABOVE at this late stage is GOING TO SWAY my view!
SEE:http://securities.stanford.edu/filings-documents/1037/NWBO_01/200881_r01c_0701254.pdf
Don't forget there are two reverse stock splits:
1/15
1/16
Both were PRE 2013
DIFFERENT STROKES FOR DIFFERENT FOLKS
Respond |
View Replies (1)
=======================================================
maverick_1 Thursday, 07/07/16 10:56:34 PM
Re: iwasadiver post# 66343 0
Post # of 416286
Screening Halt (mid Aug 2015) caused the PRECIPITOUS (ie ~Zion's Natl Pks Angel Trail FALL):NWBO's descent to near death)obviously with theBIG assist from AFraudstein Manipulators along with the close to being in the casket effect from the Phase V report.
So with NO ONE of REPUTE to handle the uncertainty amongst institutional holders and more importantly, that of non diversified retail hands with deep pockets which only an institution can provide...... this clearly explains the horrific devastation to NWBO shrs. WHY do you think I've emphasized the need for a Baker Bros since Aug 2014.
HAD CEO Linda Powers done it's $130 mln of underwritings that has been handled by HC Wainwright (big fees but NO after market support!!) and INSTEAD decided to use Charden Capital with Dr. Gbola Amusa MD CFA on board since 2014,..... you would have NOT had this experience PERIOD! Proper placement of those $130 mln of NWBO shares ARE KEY!
Clearly NWBO Bd of Dir. Dr. Navid Malik had to be responsible for introducing NWBO to Woodford as well as in Tuesday's small direct private placement done by Charden Capital due in no small part to Navid's friendship with Dr. Gbola Amusa MD CFA
So without a strong foundation of US investor support mechanism in place, it has been EASY PICKINGS for AFraudstein's VAST Manipulator Network to DISTORT, FABRICATE: witness the aftermath of PhaseV report!! and the dissension it caused for Neil Woodford. It would not have happened to ie, Baker Bros
Great science.... but without the key necessary ingredients in place of both an experienced FDA Regulatory Affairs especially in PH 3 AND the clearly necessary after market support
As a public company, science can only take you so far, especially if one wants to go it alone.With very few exceptions, way too nerve wracking for an investor.
IMHO it did NOT have to happen this way!
My 2 cents.
Adam_Feuerstein
RE: maverick_1 post# 66345
Post# of 416286 Go
Friday, 07/08/2016 07:23:15 AM
PlusOneCoin Icon
0
Who is AFraudstein?
He sounds like a very powerful, influential guy.
Respond |
No Replies
doingmybest
RE: maverick_1 post# 66345
Post# of 416286 Go
Friday, 07/08/2016 10:05:05 AM
PlusOneCoin Icon
0
Maverick, I agree with your points. I have said that NWBO has tried to fight a war on two fronts, eluding both the grip of Wall St by trying to arrange its own financings rather than using typical financing arrangements with associated fees,... while also trying to avoid the grip of BP which could entail NWBO selling off a substantial piece of future potential revenue for a partnership early on. This is bold and a lot to try to do with each of these fronts requiring a lot of strategizing and execution. The Cognate relationship is part of their financing plan to avoid the need to finance an entire mfg network themselves. The halt was unfortunately a serious kink in the plans and I see them as fighting to hold on. I think they have the goods, just need to hold on a little longer.
Respond |
No Replies
AI
